Ets-1 upregulates HER2-induced MMP-1 expression in breast cancer cells
- 11 October 2008
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 377 (2) , 389-394
- https://doi.org/10.1016/j.bbrc.2008.09.135
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Breast cancer progression: insights into multifaceted matrix metalloproteinasesClinical & Experimental Metastasis, 2007
- Evaluation of Clinical Outcomes According to HER2 Detection by Fluorescence In Situ Hybridization in Women with Metastatic Breast Cancer Treated with TrastuzumabClinical Breast Cancer, 2005
- Targeting HER2 as a therapeutic strategy for breast cancer: a paradigmatic shift of drug development in oncologyAnnals of Oncology, 2005
- Associations and Interactions between Ets-1 and Ets-2 and Coregulatory Proteins, SRC-1, AIB1, and NCoR in Breast CancerClinical Cancer Research, 2005
- Expression of the transcription factor Ets-1 is an independent prognostic marker for relapse-free survival in breast cancerOncogene, 2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Role of Ets Transcription Factors in Mammary Gland Development and OncogenesisJournal of Mammary Gland Biology and Neoplasia, 2001
- Ets target genes: past, present and futureOncogene, 2000
- Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancerBritish Journal of Cancer, 1992
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989